Novo Nordisk A S (NVO)

Historical Portfolio Holders from 2014 to 2024

All holders as of
Q1 2024
Type / Class
Equity / ADR
Shares, Excl. Options Q1 2024
$309M
Holdings value Q1 2024
$39.7B
Value change Q1 2024
+$1.75B
Grand Portfolio weight change Q1 2024
+0.004%
Number of holders
1739
Number of Buys Q1 2024
973
Number of Sells Q1 2024
-532
Average Buys Q1 2024 %
+0.02%
Average Sells Q1 2024 %
-0.007%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Filings
Period Shares, Excl. Options Value, Excl. Options Change Price Filings
2024 Q1 309M $39.7B +$1.75B $128.40 1,724
2023 Q4 296M $30.9B +$658M $103.45 1,507
2023 Q3 297M $27B +$14B $90.94 1,307
2023 Q2 143M $23.1B +$365M $161.83 1,212
2023 Q1 141M $21.9B -$263M $159.14 1,148
2022 Q4 143M $19.3B +$778M $135.34 1,050
2022 Q3 138M $13.8B -$803M $99.63 917
2022 Q2 148M $16.6B +$1.49B $111.43 938
2022 Q1 138M $15.2B +$1.12B $111.05 910
2021 Q4 132M $14.7B -$51.5M $112.00 895
2021 Q3 132M $12.7B +$106M $96.01 812
2021 Q2 131M $11B +$53.4M $83.77 745
2021 Q1 131M $8.86B -$147M $67.42 709
2020 Q4 136M $9.53B -$165M $69.85 711
2020 Q3 139M $9.67B -$173M $69.43 667
2020 Q2 143M $9.35B -$762M $65.48 674
2020 Q1 158M $9.5B -$661M $60.20 656
2019 Q4 171M $9.89B -$37.2M $57.88 654
2019 Q3 172M $8.88B +$107M $51.70 581
2019 Q2 174M $8.9B +$72.3M $51.04 569
2019 Q1 175M $9.18B +$156M $52.31 592
2018 Q4 173M $7.99B +$309M $46.07 563
2018 Q3 167M $7.88B +$214M $47.14 573
2018 Q2 164M $7.56B +$43.8M $46.12 553
2018 Q1 164M $8.07B +$36.6M $49.25 570
2017 Q4 164M $8.82B +$490M $53.67 566
2017 Q3 158M $7.59B +$319M $48.15 508
2017 Q2 153M $6.58B -$222M $42.89 500
2017 Q1 161M $5.53B +$268M $34.28 479
2016 Q4 156M $5.59B -$493M $35.86 496
2016 Q3 186M $7.75B -$621M $41.59 521
2016 Q2 193M $10.4B +$6.31M $53.78 537
2016 Q1 194M $10.5B +$174M $54.19 543
2015 Q4 195M $11.3B -$67.6M $58.08 556
2015 Q3 197M $10.7B +$223M $54.24 533
2015 Q2 199M $10.8B +$241M $54.76 525
2015 Q1 197M $10.5B +$318M $53.39 512
2014 Q4 195M $8.27B +$14M $42.32 505
2014 Q3 189M $8.98B +$38M $47.62 475
2014 Q2 189M $8.71B -$240M $46.19 478
2014 Q1 183M $8.33B +$6.68B $45.65 472